Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,835 | 30 | 96.6% |
| Education | $65.38 | 4 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $671.88 | 9 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $620.89 | 12 | $0 (2018) |
| Alkermes, Inc. | $241.76 | 3 | $0 (2018) |
| Allergan, Inc. | $220.88 | 7 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $114.87 | 1 | $0 (2017) |
| Indivior Inc. | $15.98 | 1 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $14.07 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $47.48 | 2 | Otsuka America Pharmaceutical, Inc. ($47.48) |
| 2020 | $31.38 | 2 | Allergan, Inc. ($31.38) |
| 2019 | $14.07 | 1 | Neurocrine Biosciences, Inc. ($14.07) |
| 2018 | $946.99 | 16 | Otsuka America Pharmaceutical, Inc. ($370.93) |
| 2017 | $860.41 | 13 | Sunovion Pharmaceuticals Inc. ($362.55) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/20/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: PSYCHIATRY | ||||||
| 02/20/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $114.90 | General |
| Category: CNS | ||||||
| 10/25/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $116.85 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.73 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2018 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Education | In-kind items and services | $1.91 | General |
| Category: CNS | ||||||
| 08/07/2018 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: OUD | ||||||
| 05/22/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 05/17/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: CNS | ||||||
| 05/02/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $119.83 | General |
| Category: CNS | ||||||
| 03/28/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $120.36 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: CNS | ||||||
| 03/05/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $104.15 | General |
| Category: CNS | ||||||
| 02/09/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: CNS | ||||||
| 02/09/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: CNS | ||||||
| 01/24/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: CNS | ||||||
| 11/01/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: CNS | ||||||
| 10/19/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $108.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $105.19 | General |
| Category: CNS | ||||||
| 06/15/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 21 | 69 | $14,126 | $4,318 |
| 2022 | 1 | 11 | 70 | $13,898 | $3,911 |
| 2021 | 2 | 78 | 282 | $52,716 | $18,490 |
| 2020 | 4 | 106 | 408 | $73,401 | $28,242 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 69 | $14,126 | $4,318 | 30.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 70 | $13,898 | $3,911 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 133 | $25,237 | $10,180 | 40.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 149 | $27,480 | $8,310 | 30.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 58 | 317 | $60,151 | $23,964 | 39.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 25 | 45 | $7,946 | $2,436 | 30.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 27 | $3,470 | $1,270 | 36.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 11 | 19 | $1,835 | $572.34 | 31.2% |
About Dr. Joseph Scott, DO
Dr. Joseph Scott, DO is a Psychiatry healthcare provider based in Biddeford, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2012. The National Provider Identifier (NPI) number assigned to this provider is 1346503380.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Scott, DO has received a total of $1,900 in payments from pharmaceutical and medical device companies, with $47.48 received in 2021. These payments were reported across 34 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,835).
As a Medicare-enrolled provider, Scott has provided services to 216 Medicare beneficiaries, totaling 829 services with total Medicare billing of $54,961. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Biddeford, ME
- Active Since 06/22/2012
- Last Updated 01/30/2017
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346503380
Products in Payments
- LATUDA (Drug) $620.89
- ABILIFY MAINTENA (Drug) $373.83
- REXULTI (Drug) $298.05
- Aristada 441 mg (Drug) $239.85
- VRAYLAR (Drug) $220.88
- BELSOMRA (Drug) $114.87
- SUBLOCADE (Drug) $15.98
- INGREZZA (Drug) $14.07
- Vivitrol 380 mg (Drug) $1.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Biddeford
John Huszonek, Md, MD
Psychiatry — Payments: $563.34
Dr. Vanessa Katon, D.o, D.O
Psychiatry — Payments: $118.36
Leslie Dixon, Md, MD
Psychiatry — Payments: $78.76
David Bourne, Md, MD
Psychiatry — Payments: $25.81
Dr. Donald Mcnally, D.o, D.O
Psychiatry — Payments: $21.84
Andrew Hinkens, Md, MD
Psychiatry — Payments: $15.02